Category
All
New Technology
Service & Software
Internet & Communication
Electronics & Semiconductor
Pharma & Healthcare
Other
Energy & Power
Agriculture
Consumer Goods
Machinery & Equipment
Food & Beverages
Medical Care
Automobile & Transportation
Packaging
Chemical & Material
Medical Devices & Consumables
Category
All
Total: 2 records, 1 pages
Search For: Monoclonal Mouse Antibody
Global Monoclonal Mouse Antibody Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
02 Jan 2024
Medical Care
According to our (Global Info Research) latest study, the global Monoclonal Mouse Antibody market size was valued at USD 9246.8 million in 2023 and is forecast to a readjusted size of USD 12260 million by 2030 with a CAGR of 4.1% during review period.
USD3480.00
Add To Cart
Global Monoclonal Mouse Antibody Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
18 Mar 2023
Medical Care
Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.
USD3480.00
Add To Cart
Popular Product Keywords
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
Search For: Monoclonal Mouse Antibody
Total: 2 records, 1 pages
According to our (Global Info Research) latest study, the global Monoclonal Mouse Antibody market size was valued at USD 9246.8 million in 2023 and is forecast to a readjusted size of USD 12260 million by 2030 with a CAGR of 4.1% during review period.
USD3480.00
Add To Cart
Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.
USD3480.00
Add To Cart
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
-
- Digging deeper into global industry information and providing market strategies.Contact Us >>